Inger Skånberg Selected Research

tesaglitazar

1/2012	Tesaglitazar, a dual PPAR-α/γ agonist, hamster carcinogenicity, investigative animal and clinical studies.
2/2011	Proliferative and molecular effects of the dual PPARalpha/gamma agonist tesaglitazar in rat adipose tissues: relevance for induction of fibrosarcoma.
7/2007	Tesaglitazar, a PPARalpha/gamma agonist, induces interstitial mesenchymal cell DNA synthesis and fibrosarcomas in subcutaneous tissues in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Inger Skånberg Research Topics

Disease

2	Fibrosarcoma 02/2011 - 07/2007
1	Hemangiosarcoma (Angiosarcoma) 01/2012
1	Hemangioma (Angioma) 01/2012
1	Hepatocellular Carcinoma (Hepatoma) 01/2012
1	Hypertrophy 01/2012
1	Inflammation (Inflammations) 02/2011
1	Fibrosis (Cirrhosis) 02/2011
1	Neoplasms (Cancer) 07/2007

Drug/Important Bio-Agent (IBA)

3	tesaglitazarIBA 01/2012 - 07/2007
2	PPAR alphaIBA 02/2011 - 07/2007
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2011
1	Dihydrotachysterol (AT 10)IBA 07/2007
1	DNA (Deoxyribonucleic Acid)IBA 07/2007
1	Bromodeoxyuridine (BrdU)IBA 07/2007
1	PPAR gammaIBA 07/2007